1. Home
  2. BIO vs S Comparison

BIO vs S Comparison

Compare BIO & S Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • S
  • Stock Information
  • Founded
  • BIO 1952
  • S 2013
  • Country
  • BIO United States
  • S United States
  • Employees
  • BIO N/A
  • S N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • S EDP Services
  • Sector
  • BIO Industrials
  • S Technology
  • Exchange
  • BIO Nasdaq
  • S Nasdaq
  • Market Cap
  • BIO 9.1B
  • S 8.7B
  • IPO Year
  • BIO N/A
  • S 2021
  • Fundamental
  • Price
  • BIO $322.15
  • S $28.37
  • Analyst Decision
  • BIO Strong Buy
  • S Buy
  • Analyst Count
  • BIO 4
  • S 26
  • Target Price
  • BIO $411.00
  • S $28.92
  • AVG Volume (30 Days)
  • BIO 211.4K
  • S 3.2M
  • Earning Date
  • BIO 10-30-2024
  • S 12-04-2024
  • Dividend Yield
  • BIO N/A
  • S N/A
  • EPS Growth
  • BIO N/A
  • S N/A
  • EPS
  • BIO N/A
  • S N/A
  • Revenue
  • BIO $2,580,209,000.00
  • S $723,632,000.00
  • Revenue This Year
  • BIO N/A
  • S $33.89
  • Revenue Next Year
  • BIO $3.61
  • S $26.13
  • P/E Ratio
  • BIO N/A
  • S N/A
  • Revenue Growth
  • BIO N/A
  • S 38.04
  • 52 Week Low
  • BIO $262.12
  • S $14.33
  • 52 Week High
  • BIO $387.99
  • S $30.76
  • Technical
  • Relative Strength Index (RSI)
  • BIO 39.02
  • S 59.64
  • Support Level
  • BIO $306.42
  • S $25.82
  • Resistance Level
  • BIO $387.99
  • S $28.42
  • Average True Range (ATR)
  • BIO 12.82
  • S 0.81
  • MACD
  • BIO -5.89
  • S -0.02
  • Stochastic Oscillator
  • BIO 21.17
  • S 86.13

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About S SentinelOne Inc.

SentinelOne is a cloud-based cybersecurity company specializing in endpoint protection. SentinelOne's primary offering is its Singularity platform that offers a single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The California-based firm was founded in 2013 and went public in 2021.

Share on Social Networks: